Log in to save to my catalogue

Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project

Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_717325314b0d485b9dbdbefd5aa3eae4

Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project

About this item

Full title

Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceuticals (Basel, Switzerland), 2020-12, Vol.13 (12), p.466

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Background and aim: Disease-modifying therapies (DMTs) used in multiple sclerosis (MS) have distinct safety profiles. In this paper, we report preliminary results of an on-going pharmacovigilance project (the FASM study). Results: Neurologists working at involved multiple sclerosis centers collected 272 Individual Case Safety Reports (ICSRs). Adver...

Alternative Titles

Full title

Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_717325314b0d485b9dbdbefd5aa3eae4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_717325314b0d485b9dbdbefd5aa3eae4

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph13120466

How to access this item